Cencora reaches $111.3M settlement of derivative suit over opioid oversight

Cencora, Inc.

Insurance carriers to pay Cencora $111.3M (less attorney fees) to settle derivative claims over controlled substance diversion controls.
Settlement subject to Delaware Chancery Court approval; defendants deny any wrongdoing or liability.
Derivative complaint alleged breach of fiduciary duty by directors and officers for failing to monitor opioid compliance.
Special Litigation Committee investigated and mediated the resolution; $111.25M mediator proposal accepted June 2025.
Settlement separate from Cencora's prior $6.4B nationwide opioid distributor settlement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.